HIGHLIGHTS
- who: Maria V. Konopleva et al. from the (UNIVERSITY) have published the paper: Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro, in the Journal: Vaccines 2021, 9, x FOR PEER REVIEW 1 of /2021/
- what: The main reason for the ineffectiveness of postvaccination antibodies against the G145R mutant is the mutant's distinct antigenic properties. This study demonstrated for the first time, using the preculturing model, a major difference in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.